NO20044097L - Medikamenter inneholdende steroider og et nytt anticholinesteraselegemiddel - Google Patents

Medikamenter inneholdende steroider og et nytt anticholinesteraselegemiddel

Info

Publication number
NO20044097L
NO20044097L NO20044097A NO20044097A NO20044097L NO 20044097 L NO20044097 L NO 20044097L NO 20044097 A NO20044097 A NO 20044097A NO 20044097 A NO20044097 A NO 20044097A NO 20044097 L NO20044097 L NO 20044097L
Authority
NO
Norway
Prior art keywords
new
medications containing
containing steroids
anticholinesterase drug
anticholinesterase
Prior art date
Application number
NO20044097A
Other languages
English (en)
Norwegian (no)
Inventor
Georg Speck
Richard Reichl
Christopher John Montagu Meade
Helmut Meissner
Gerd Morschhauser
Michael P Pieper
Gerald Pohl
Rolf Banholzer
Michel Pairet
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20044097L publication Critical patent/NO20044097L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20044097A 2002-04-12 2004-09-27 Medikamenter inneholdende steroider og et nytt anticholinesteraselegemiddel NO20044097L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216429A DE10216429A1 (de) 2002-04-12 2002-04-12 Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
PCT/EP2003/003668 WO2003086399A1 (de) 2002-04-12 2003-04-09 Arzneimittel enthaltend steroide und ein neues anticholinergikum

Publications (1)

Publication Number Publication Date
NO20044097L true NO20044097L (no) 2004-11-04

Family

ID=28458802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044097A NO20044097L (no) 2002-04-12 2004-09-27 Medikamenter inneholdende steroider og et nytt anticholinesteraselegemiddel

Country Status (29)

Country Link
EP (2) EP1621197A3 (sr)
JP (1) JP4559086B2 (sr)
KR (1) KR101010869B1 (sr)
CN (1) CN1646126A (sr)
AR (1) AR039275A1 (sr)
AT (1) ATE312607T1 (sr)
AU (1) AU2003216921B2 (sr)
BR (1) BR0309085A (sr)
CA (1) CA2481268C (sr)
DE (2) DE10216429A1 (sr)
DK (1) DK1496902T3 (sr)
EA (1) EA008386B1 (sr)
EC (1) ECSP045355A (sr)
ES (1) ES2254917T3 (sr)
HR (1) HRP20040943B1 (sr)
IL (2) IL164391A0 (sr)
ME (1) MEP54208A (sr)
MX (1) MXPA04009917A (sr)
MY (1) MY137045A (sr)
NO (1) NO20044097L (sr)
NZ (1) NZ536284A (sr)
PE (1) PE20040326A1 (sr)
PL (1) PL211227B1 (sr)
RS (1) RS50776B (sr)
TW (1) TWI311055B (sr)
UA (1) UA80125C2 (sr)
UY (1) UY27758A1 (sr)
WO (1) WO2003086399A1 (sr)
ZA (1) ZA200406751B (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
MY137522A (en) 2001-04-30 2009-02-27 Glaxo Group Ltd Novel anti-inflammatory androstane derivatives.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP4819699B2 (ja) 2004-02-06 2011-11-24 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
SI3106149T1 (sl) 2009-05-29 2020-07-31 Pearl Therapeutics, Inc. Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
HK1219059A1 (zh) 2013-03-15 2017-03-24 珍珠治疗公司 用於微粒晶体材料的状态调节的方法和系统
CN115282411A (zh) * 2022-01-14 2022-11-04 温州医科大学 利用鼻嗅区递送药物入脑的输送系统及其应用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
PT83094B (pt) 1985-07-30 1993-07-30 Glaxo Group Ltd Dispositivos proprios para a administracao de medicamentos a pacientes
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
AU700837B2 (en) * 1995-04-28 1999-01-14 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
CA2436540C (en) * 2000-10-31 2008-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and corticosteroids

Also Published As

Publication number Publication date
TWI311055B (en) 2009-06-21
ES2254917T3 (es) 2006-06-16
KR101010869B1 (ko) 2011-01-26
CA2481268A1 (en) 2003-10-23
MEP54208A (en) 2011-05-10
IL164391A0 (en) 2005-12-18
BR0309085A (pt) 2005-02-09
DK1496902T3 (da) 2006-05-08
EP1496902B1 (de) 2005-12-14
RS50776B (sr) 2010-08-31
KR20050000391A (ko) 2005-01-03
ECSP045355A (es) 2005-01-28
PL211227B1 (pl) 2012-04-30
ATE312607T1 (de) 2005-12-15
HRP20040943B1 (hr) 2013-05-31
CA2481268C (en) 2011-07-12
AU2003216921A1 (en) 2003-10-27
TW200403062A (en) 2004-03-01
WO2003086399A1 (de) 2003-10-23
PE20040326A1 (es) 2004-07-13
NZ536284A (en) 2006-11-30
AU2003216921B2 (en) 2008-03-13
MXPA04009917A (es) 2004-12-07
EP1621197A3 (de) 2010-01-06
JP2005529105A (ja) 2005-09-29
JP4559086B2 (ja) 2010-10-06
EP1621197A2 (de) 2006-02-01
EA200401303A1 (ru) 2005-04-28
EA008386B1 (ru) 2007-04-27
DE50301934D1 (de) 2006-01-19
MY137045A (en) 2008-12-31
PL371561A1 (en) 2005-06-27
IL164391A (en) 2010-11-30
EP1496902A1 (de) 2005-01-19
UA80125C2 (en) 2007-08-27
HRP20040943A2 (en) 2005-04-30
ZA200406751B (en) 2006-12-27
DE10216429A1 (de) 2003-10-23
AR039275A1 (es) 2005-02-16
UY27758A1 (es) 2003-11-28
CN1646126A (zh) 2005-07-27
RS89904A (sr) 2006-10-27

Similar Documents

Publication Publication Date Title
DK1467789T3 (da) Lægemiddeldispenser
DK1509266T3 (da) System omfattende en dyse og et holdersystem
NO20044097L (no) Medikamenter inneholdende steroider og et nytt anticholinesteraselegemiddel
AU154431S (en) Multi-panel computer display
NO20052860D0 (no) Farmasoytiske pelletter omfattende tamsulosin og en fremgangsmate for fremstilling av samme
EP1605895A4 (en) ORAL INSULIN THERAPIES AND PROTOCOL
NO20032992D0 (no) System og fremgangsmåte for implementering av en teller
EP1387385A4 (en) PLASMA DISPLAY
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
DE60231189D1 (de) Ng sowie plasmaanzeigevorrichtung
EP1381013A4 (en) PLASMA DISPLAY
EP1495322A4 (en) HETEROKLITIC ANALOGUES AND ASSOCIATED METHODS
EP1750693A4 (en) OKULOSELECTIVE MEDICINAL PRODUCTS AND PRODRUGS
FR2870539B1 (fr) Nouvelles methodes et medicaments
NO20033709D0 (no) Medisinske preparater omfattende Diklofenak og Ornoprostil
EP1692125A4 (en) IRCINIASTATINES A AND B
EP1456647A4 (en) METHOD FOR IDENTIFYING AND VALIDATING POTENTIAL DRUG TARGETS
ZA200406881B (en) Medicaments containing betamimetic drugs and a novel anticholineterase drug
NO20041649L (no) Et kombinasjonsprodukt omfattende melagatran og dexametason
EP1475090A4 (en) DRUG AGAINST MITOCHONDRIAL DISEASES
SI1496902T1 (sl) Zdravilo, vsebujoce steroide in nov antiholinergik
FR2838313B1 (fr) Capsule a diffuseur escamotable
GB0209549D0 (en) Medication assembling device
GB2390437B (en) A display device
ITBO20020321A1 (it) Dispositivo contenitore ed espositore per gioielli

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application